Johns Hopkins ABX Guide
Dengue vaccine
VACCINE TYPE
- Dengvaxia®, or the Dengue Tetravalent Vaccine, is a live, attenuated vaccine active against dengue virus serotypes 1, 2, 3 and 4.
- Approved for use in individuals 9 through 16 years of age with laboratory-confirmed previous dengue infection AND who lived in an endemic area.
- The vaccine is built on a yellow fever backbone component.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 17, 2023
Citation
Dzintars, Kathryn. "Dengue Vaccine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540769/3/Dengue_vaccine.
Dzintars K. Dengue vaccine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540769/3/Dengue_vaccine. Accessed April 19, 2024.
Dzintars, K. (2023). Dengue vaccine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540769/3/Dengue_vaccine
Dzintars K. Dengue Vaccine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. [cited 2024 April 19]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540769/3/Dengue_vaccine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dengue vaccine
ID - 540769
A1 - Dzintars,Kathryn,PharmD, BCPS
Y1 - 2023/01/17/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540769/3/Dengue_vaccine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
